SEARCH

SEARCH BY CITATION

References

  • 1
    Gerd Bouma WS. The immunological and genetic basis of inflammatory bowel disease. Nature Rev Immunol 2003; 3: 52133.
  • 2
    Podolsky D. Lessons from genetic models of inflammatory bowel disease. Acta Gastroenterol Belg 1997; 60: 1635.
  • 3
    Cantorna MT. Vitamin D and autoimmunity: is vitamin D status an environmental factor affecting autoimmune disease prevalence? Proc Soc Exp Biol Med 2000; 223: 2303.
  • 4
    Sentongo TA, Semaeo EJ, Stettler N, Piccoli DA, Stallings VA, Zemel BS. Vitamin D status in children, adolescents, and young adults with Crohn disease. Am J Clin Nutr 2002; 76: 107781.
  • 5
    Cantorna MT, Humpal-Winter J, DeLuca HF. In vivo upregulation of interleukin-4 is one mechanism underlying the immunoregulatory effects of 1,25-dihydroxyvitamin D(3). Arch Biochem Biophys 2000; 377: 1358.
  • 6
    Simmons JD , Mulligan C, Welsh KI, Jewell DP. Vitamin D receptor gene polymorphism: association with Crohn's disease susceptibility. Gut 2000; 47: 21114.
  • 7
    Kreutz M, Andreesen R, Krause S, Szabo A, Ritz E, Reichel H. 1,25-dihydroxyvitamin D3 production and vitamin D3 receptor expression are developmentally regulated during differentiation of human monocytes into macrophages. Blood 1993; 82: 13007.
  • 8
    Deluca HF, Cantorna MT. Vitamin D. Its role and uses in immunology. Faseb J 2001; 15: 257985.
  • 9
    Marcinkowska E. A run for a membrane vitamin D receptor. Biol Signals Recept 2001; 10: 3419.
  • 10
    Meehan TF, DeLuca HF. The vitamin D receptor is necessary for 1alpha,25-dihydroxyvitamin D(3) to suppress experimental autoimmune encephalomyelitis in mice. Arch Biochem Biophys 2002; 408: 2004.
  • 11
    Rigby WF, Stacy T, Fanger MW. Inhibition of T lymphocyte mitogenesis by 1,25-dihydroxyvitamin D3 (calcitriol). J Clin Invest 1984; 74: 14515.
  • 12
    Lemire JM. Immunomodulatory role of 1,25-dihydroxyvitamin D3. J Cell Biochem 1992; 49: 2631.
  • 13
    Adorini L, Penna G, Giarratana N, Roncari A, Amuchastegui S, Daniel KC, Uskokovic M. Dendritic cells as key targets for immunomodulation by Vitamin D receptor ligands. J Steroid Biochem Mol Biol 2004; 89–90: 43741.
  • 14
    Froicu M, Weaver V, Wynn TA, McDowell MA, Welsh JE, Cantorna MT. A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol Endocrinol 2003; 17: 238692.
  • 15
    Cantorna MT, Munsick C, Bemiss C, Mahon BD. 1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. J Nutr 2000; 130: 264852.
  • 16
    Germain RN. T-cell development and the CD4-CD8 lineage decision. Nature Rev Immunol 2002; 2: 30922.
  • 17
    Ashwell JD, King LB, Vacchio MS. Cross-talk between the T cell antigen receptor and the glucocorticoid receptor regulates thymocyte development. Stem Cells 1996; 14: 490500.
  • 18
    Lindsay JO, Hodgson HJ. Review article: the immunoregulatory cytokine interleukin-10 – a therapy for Crohn's disease? Aliment Pharmacol Ther 2001; 15: 170916.
  • 19
    Van Deventer SJ. Immunomodulation of Crohn's Disease. Curr Dir Autoimmun 2000; 2: 15066.
  • 20
    Zhu Y, Mahon BD, Froicu M, Cantorna MT. Calcium and 1alpha,25-dihydroxyvitamin D3 target the TNF-alpha pathway to suppress experimental inflammatory bowel disease. Eur J Immunol 2004; 35: 21724.
  • 21
    Rennick DM, Fort MM. Lessons from genetically engineered animal models. XII. IL-10-deficient (IL-10–/–) mice and intestinal inflammation. Am J Physiol Gastrointest Liver Physiol 2000; 278: G82933.
  • 22
    Ludwiczek O, Vannier E, Borggraefe I, Kaser A, Siegmund B, Dinarello CA, Tilg H. Imbalance between interleukin-1 agonists and antagonists: relationship to severity of inflammatory bowel disease. Clin Exp Immunol 2004; 138: 329.
  • 23
    Giulietti A, Gysemans, Stoffels K, Van Etten E, Decallonne B, Overbergh L, Bouillon R, Mathieu C. Vitamin D deficiency in early life accelerates Type 1 diabetes in non-obese diabetic mice. Diabetologia 2004; 47: 45162.
  • 24
    Tsoukas CDWD, Escobar SS, Provvedini DM, Dinarello CA, Hustmyer FG, Manolagas SC. Inhibition of interleukin-1 production by 1,25-dihydroxyvitamin D3. J Clin Endocrinol Metab 1989; 69: 12733.
  • 25
    Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993; 75: 26374.
  • 26
    Amsen D, Kruisbeek AM. Thymocyte selection: not by TCR alone. Immunol Rev 1998; 165: 20929.
  • 27
    Cohen J. Glucocorticoid-induced apoptosis in the thymus. Semin Immunol 1992; 4: 3639.
  • 28
    Zuckerman SH, Shellhaas J, Butler LD. Differential regulation of lipopolysaccharide-induced interleukin 1 and tumor necrosis factor synthesis: effects of endogenous and exogenous glucocorticoids and the role of the pituitary-adrenal axis. Eur J Immunol 1989; 19: 3015.
  • 29
    Lewis R. Calcium signaling mechanisms in T lymphocytes. Annu Rev Immunol 2001; 19: 497521.